Paul Kotwinski
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Cardiac Imaging and Diagnostics, Menopause: Health Impacts and Treatments
Most-Cited Works
- → Estrogen Receptor α Gene Variation and the Risk of Stroke(2005)98 cited
- → Estrogen Receptor α Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts(2006)91 cited
- → Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer(2016)46 cited
- → Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart(2006)30 cited
- → Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients(2017)13 cited
- → The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure(2004)11 cited
- → Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity(2009)6 cited
- → The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity(2013)4 cited
- → CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging(2013)3 cited
- → 018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity: Abstract 018 Table 1(2012)1 cited